Clinical management of the organ donor
R Arbour - AACN Advanced Critical Care, 2005 - AACN
There is a critical mismatch between available organs for transplant and acutely or critically
ill patients with end-stage organ disease. Patients who may benefit from organ …
ill patients with end-stage organ disease. Patients who may benefit from organ …
Manuseio do potencial doador de múltiplos órgãos
TH Rech, ÉM Rodrigues Filho - Revista Brasileira de Terapia …, 2007 - SciELO Brasil
JUSTIFICATIVA E OBJETIVOS: O transplante de órgãos sólidos vem sendo considerado o
tratamento de eleição para várias doenças terminais que afetam rim, pâncreas, fígado …
tratamento de eleição para várias doenças terminais que afetam rim, pâncreas, fígado …
Selection and management of the lung donor
GI Snell, GP Westall - Clinics in chest medicine, 2011 - chestmed.theclinics.com
The sources of donor organs for use in lung transplant (LTx) and the selection criteria used
have taken a quantum leap forward in the last few years. Novel sources of lungs are being …
have taken a quantum leap forward in the last few years. Novel sources of lungs are being …
Thyroid hormone in cardiac surgery
AM Ranasinghe, RS Bonser - Vascular pharmacology, 2010 - Elsevier
Thyroid hormone has a wide range of cardiovascular effects which are mediated at both
genomic and non-genomic levels. As a stress response to surgery, the non-thyroidal illness …
genomic and non-genomic levels. As a stress response to surgery, the non-thyroidal illness …
Controversial points in organ donor management
C Chamorro, JA Falcón, JC Michelena - Transplantation proceedings, 2009 - Elsevier
There are still many controversial aspects regarding which method is best for managing
organ donors to prevent, lessen, or even reverse the organ alterations associated with brain …
organ donors to prevent, lessen, or even reverse the organ alterations associated with brain …
How to increase the utilization of donor hearts?
M Guglin - Heart failure reviews, 2015 - Springer
Cardiac transplantation is the best treatment available for patients with end-stage
cardiomyopathy. Shortage of donor hearts is the main factor limiting the use of this treatment …
cardiomyopathy. Shortage of donor hearts is the main factor limiting the use of this treatment …
Overcoming the Challenges Now Limiting Islet Transplantation.
A Pileggi, L Cobianchi, L Inverardi… - Annals of the New …, 2006 - search.ebscohost.com
Steady improvements in islet cell processing technology and immunosuppressive protocols
have made pancreatic islet transplantation a clinical reality for the treatment of patients with …
have made pancreatic islet transplantation a clinical reality for the treatment of patients with …
Organ donation and time to procurement: late is not too late
K Inaba, BC Branco, L Lam, A Salim… - Journal of Trauma …, 2010 - journals.lww.com
Background: No consensus exists as to the maximal period of time allowable after brain
death (BD) before organ procurement rates begin to deteriorate. The aim of this study was to …
death (BD) before organ procurement rates begin to deteriorate. The aim of this study was to …
17β-estradiol and methylprednisolone association as a therapeutic option to modulate lung inflammation in brain-dead female rats
M Vidal-dos-Santos, LF Anunciação… - Frontiers in …, 2024 - frontiersin.org
Introduction Brain death (BD) is known to compromise graft quality by causing
hemodynamic, metabolic, and hormonal changes. The abrupt reduction of female sex …
hemodynamic, metabolic, and hormonal changes. The abrupt reduction of female sex …
[HTML][HTML] Vasopressin Use in the Support of Organ Donors: Physiological Rationale and Review of the Literature
S Ouerd, AJ Frenette, D Williamson, K Serri… - Critical Care …, 2023 - journals.lww.com
OBJECTIVES: The objective of this review was to depict the physiological and clinical
rationale for the use of vasopressin in hemodynamic support of organ donors. After …
rationale for the use of vasopressin in hemodynamic support of organ donors. After …